JWH-251
JWH-251[edit]
JWH-251 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the naphthoylindole family of compounds and is used in scientific research to study the endocannabinoid system.
Chemical Properties[edit]
JWH-251 is chemically classified as a naphthoylindole, which is a type of synthetic cannabinoid. Its full chemical name is 2-(2-methylphenyl)-1-(1-pentylindol-3-yl)ethanone. The compound has a molecular formula of C25H25NO and a molecular weight of 355.48 g/mol.
Pharmacology[edit]
JWH-251 acts as a full agonist at both the CB1 and CB2 cannabinoid receptors, with a higher affinity for the CB1 receptor. This interaction with the cannabinoid receptors is responsible for its psychoactive effects, which mimic those of tetrahydrocannabinol (THC), the primary active component of cannabis.
Effects[edit]
The effects of JWH-251 are similar to those of other synthetic cannabinoids and include euphoria, altered perception, and relaxation. However, due to its potency, it can also cause adverse effects such as anxiety, paranoia, and tachycardia. The use of JWH-251 and similar compounds has been associated with a number of health risks, particularly when used in unregulated products.
Legal Status[edit]
The legal status of JWH-251 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."
